For Medicaid-Insured Patients with Cancer, Health Insurance Does Not Always Mean Health Access
Although there has been a significant increase in the number of U.S. residents insured through Medicaid since the expansion of the Patient Protection and Afforadble Care Act (ACA) in March 2010, the ability of Medicaid-insured patients to access...
15-Jul-2022 1:30 PM EDT
Add to Favorites
New Research on Colorectal Cancer
Michael Cecchini, MD, recently received a K08 grant from the NCI to conduct research aimed at investigating multiple clinical trials for patients with colorectal cancer. The first trial is a Phase II study in which patients will be treated with a...
13-Jul-2022 1:35 PM EDT
Add to Favorites
Defining the Landscape of Prostate Cancer Treatment
Smilow Cancer Hospital is now offering a new surgical option for prostate cancer treatment unavailable elsewhere in Connecticut, and still rare throughout the United States. The beneficiaries are men in need of a prostatectomy, a procedure in which...
11-Jul-2022 9:50 AM EDT
Add to Favorites
Bold Plans for Cancer Care at Yale
Eric Winer, MD, began his tenure at Yale in February 2022 with a vision to expand the cancer program and national prominence of Yale Cancer Center and Smilow Cancer Hospital. He is already recruiting more physicians and researchers and focusing on...
6-Jul-2022 11:05 AM EDT
Add to Favorites
Yale Scientists Develop Precision Medicine Approach to Metabolic Therapy for Breast Cancer
Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy...
20-May-2022 9:45 AM EDT
Add to Favorites
Treatment Efficacy Score a Better Way to Predict Long-Term Survival in Breast Cancer Trials
In a study led by Dr. Lajos Pusztai, Professor of Medicine (Medical Oncology) at Yale Cancer Center, researchers across various institutions, and on behalf of the I-SPY consortium, developed a novel continuous residual cancer based metric to compare...
10-May-2022 10:05 AM EDT
Add to Favorites
How do Patients Feel about Using AI in Healthcare?
New research from Yale Cancer Center provides a new understanding of patients’ views of artificial intelligence (AI) in health care. W
10-May-2022 9:35 AM EDT
Add to Favorites
Combination Immunotherapy Improves Outcomes for Patients with Non-small Cell Lung Cancer
The phase 2 clinical trial of a multi-center study known as the COAST clinical trial has demonstrated improved outcomes using immunotherapy combinations for patients with unresectable stage III non-small cell lung cancer, according to researchers at...
25-Apr-2022 9:45 AM EDT
Add to Favorites
See All News
How Patients with Cancer Can Navigate COVID-19 for the Holidays
Smilow Cancer Hospital expert has the latest recommendations for patients and families.
20-Dec-2021 8:00 AM EST
Five Ways to Lower Your Skin Cancer Risk
Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT
Yale Expert Discusses Treatment for Endometrial Cancer
Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT
Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges
Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT
Yale Expert Available to Speak on Medical Marijuana for Children with Cancer
12-Mar-2018 3:05 PM EDT
Overcoming Resistance to Immunotherapy
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT
Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial
6-Oct-2017 3:05 PM EDT
Yale Expert Wins Prestigious 2017 Warren Alpert Prize
6-Oct-2017 2:05 PM EDT
See All Experts